
Novo Nordisk Investors: Rosen Law Firm Deadline Approaching
Investors who purchased Novo Nordisk A/S (NYSE: NVO) securities between May 7 and July 28, 2025, may be eligible for compensation. Rosen Law Firm is urging those who believe they were harmed to act by the September 30, 2025, deadline. A class action lawsuit has already been filed.